Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Shruti, Saha"'
Autor:
Catherine Cohet, Brigitte Cheuvart, Leentje Moerman, Dan Bi, Adrian Caplanusi, Mallesh Kariyappa, Sanjay Lalwani, Monjori Mitra, Amita Sapru, Shruti Saha, P.V. Varughese, Rajeev Zachariah Kompithra, Sanjay Gandhi
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 11, Pp 4646-4653 (2021)
The human rotavirus vaccine (HRV; Rotarix, GSK) is available as liquid (Liq) and lyophilized (Lyo) formulations, but only Lyo HRV is licensed in India. In this phase III, randomized, open-label trial (NCT02141204), healthy Indian infants aged 6–10
Externí odkaz:
https://doaj.org/article/5d35f76d2617450b9901c97811e1abfb
Publikováno v:
Perspectives in Clinical Research, Vol 11, Iss 2, Pp 81-85 (2020)
Introduction: A key determinant of the success of any study is the recruitment and subsequent retention of participants. Screen failure and dropouts impact both the scientific validity and financial viability of any study. We carried out this audit w
Externí odkaz:
https://doaj.org/article/977d69a6c329479bb722ee222f9d26c0
Autor:
Shruti Saha, Nithya Jaideep Gogtay
Publikováno v:
Perspectives in Clinical Research, Vol 13, Iss 2, Pp 63-64 (2022)
Externí odkaz:
https://doaj.org/article/b7a88273bcdd4765b3231d9c5be9435b
Autor:
Rajeev Zachariah Kompithra, Dan Bi, Amita Sapru, Adrian Caplanusi, Shruti Saha, Leentje Moerman, Brigitte Cheuvart, Sanjay Gandhi, Mallesh Kariyappa, Sanjay Lalwani, Catherine Cohet, Monjori Mitra, P.V. Varughese
Publikováno v:
Human Vaccines & Immunotherapeutics. 17:4646-4653
The human rotavirus vaccine (HRV; Rotarix, GSK) is available as liquid (Liq) and lyophilized (Lyo) formulations, but only Lyo HRV is licensed in India. In this phase III, randomized, open-label trial (NCT02141204), healthy Indian infants aged 6-10 we
Publikováno v:
Indian journal of medical ethics. (2)
The present audit was carried out with the objective of evaluating warning letters (WLs) issued to trial sponsors, clinical investigators and institutional review boards (IRBs) by the United States Food and Drug Administration during a six-year perio
Autor:
Miteshkumar Rajaram, Maurya, Sunanda, Gautam, Jeffrey Pradeep, Raj, Shruti, Saha, Sanchita, Ambre, Aishwarya, Thakurdesai, Aditya, Shah, Urmila Mukund, Thatte
Publikováno v:
Indian journal of pharmacology. 54(2)
CYP3A5 enzymes belong to the phase I Group of drug-metabolizing enzymes, which are involved in the metabolism of 50% of the drugs. Participants with CYP3A5 genotype: CYP3A5 *1/*1 are fast metabolizers of drugs and hence will require higher dosing. Wh
Autor:
Alka Bhatia, Rohit Manoj Kumar, Lekha Saha, Amitava Chakrabarti, Neha Singh, Shruti Saha, Jagjit Singh
Publikováno v:
Rheumatology Research. 5:115-128
Currently available disease modifying anti-rheumatoid drugs have limitations like dose-dependent toxicity and tolerance.Dimethyl fumarate has demonstrated anti-inflammatory and immunomodulatory properties in various animal models. Thus, thepresent st
Publikováno v:
Indian journal of medical ethics. (2)
Predatory journals charge publication fees from authors and publish without an adequate peer review, and often do not provide editorial and/or publishing services. Our objective was to evaluate e-mail solicitations received by authors in a defined ti
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 9, Iss 11, Pp ZC19-ZC21 (2015)
Introduction: The increase of potential side effects and safety concerns of conventional medicaments have led to the recent popularity of herbal alternative medications. The herbal products are known for its high antimicrobial activity, biocompati
Externí odkaz:
https://doaj.org/article/e64be65e3a5a45d6a1ff1b02dc8d02cb
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO4-11